Please wait while we open this resource.
K
Clinical reviews
THE HEART FAILURE KNIGHTS
Department of Medicine, ASST Mantova, C. Poma Hospital, Italy
PDF202321 pages811 KB
The article provides an in-depth review of the latest guidelines and evidence regarding heart failure management, emphasizing the shift from a sequential approach to a more integrated drug therapy strategy. It highlights the efficacy of new medications like vericiguat and omecamtiv mecarbil in treating heart failure with reduced ejection fraction (HFrEF). The authors analyze clinical trial data and discuss the implications for patient care and healthcare costs.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology